{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:36:17Z","timestamp":1792856177258,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T00:00:00Z","timestamp":1424044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","krcp-ksn.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Research and Clinical Practice"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.krcp.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T19:40:02Z","timestamp":1424806802000},"page":"4-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Management of chronic kidney disease\u2013mineral and bone disorder: Korean working group recommendations"],"prefix":"10.1016","volume":"34","author":[{"given":"Eunah","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bum Soon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kook-Hwan","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheun-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.krcp.2015.02.002_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.krcp.2015.02.002_bib2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca \u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.krcp.2012.01.005","article-title":"Brief Report: Renal replacement therapy in Korea, 2010","volume":"31","author":"Jin","year":"2012","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.krcp.2015.02.002_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.krcp.2013.12.003","article-title":"Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea","volume":"33","author":"Kim","year":"2014","journal-title":"Kidney Res Clin Pract"},{"issue":"4 Suppl 3","key":"10.1016\/j.krcp.2015.02.002_bib6","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.krcp.2015.02.002_bib7","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.krcp.2015.02.002_bib8","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1111\/j.1440-1797.2006.00508.x","article-title":"The CARI guidelines. Management of bone disease, calcium, phosphate and parathyroid hormone","volume":"11","author":"Elder","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.krcp.2015.02.002_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder","volume":"17","author":"Fukagawa","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.krcp.2015.02.002_bib10","doi-asserted-by":"crossref","first-page":"c145","DOI":"10.1159\/000328066","article-title":"Renal Association Clinical Practice Guideline in mineral and bone disorders in CKD","volume":"118","author":"Steddon","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.krcp.2015.02.002_bib11","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/ndt\/gfq513","article-title":"Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement","volume":"25","author":"Goldsmith","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2015.02.002_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1542-4758.2006.00125.x","article-title":"Review of dialysate calcium concentration in hemodialysis","volume":"10","author":"Toussaint","year":"2006","journal-title":"Hemodial Int"},{"key":"10.1016\/j.krcp.2015.02.002_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-104-3-358","article-title":"Blood pressure response to changes in serum ionized calcium during hemodialysis","volume":"104","author":"Maynard","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.krcp.2015.02.002_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/ajkd.1998.v32.pm9669433","article-title":"Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients","volume":"32","author":"van der Sande","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.krcp.2015.02.002_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00005792-197311000-00005","article-title":"Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium","volume":"52","author":"Kopple","year":"1973","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.krcp.2015.02.002_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semnephrol.2012.12.018","article-title":"Management of natural and added dietary phosphorus burden in kidney disease","volume":"33","author":"Cupisti","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2215\/CJN.08601209","article-title":"Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients","volume":"5","author":"Noori","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease","volume":"5","author":"Kalantar-Zadeh","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"22 Suppl 2","key":"10.1016\/j.krcp.2015.02.002_bib19","first-page":"ii45","article-title":"EBPG guideline on nutrition","author":"Fouque","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2015.02.002_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/PPA.S43486","article-title":"Patient education for phosphorus management in chronic kidney disease","volume":"7","author":"Kalantar-Zadeh","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.krcp.2015.02.002_bib21","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","article-title":"Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?","volume":"88","author":"Shinaberger","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.krcp.2015.02.002_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2215\/CJN.04620510","article-title":"Prescribed dietary phosphate restriction and survival among hemodialysis patients","volume":"6","author":"Lynch","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2215\/CJN.05130610","article-title":"Prevention and control of phosphate retention\/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?","volume":"6","author":"Martin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib24","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.krcp.2015.02.002_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ndt\/gfr284","article-title":"Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation","volume":"27","author":"Ciceri","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2015.02.002_bib26","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1093\/ndt\/gfp137","article-title":"Arterial calcification in patients with chronic kidney disease","volume":"24","author":"Koleganova","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2015.02.002_bib27","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","article-title":"Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients","volume":"17","author":"Taniguchi","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.krcp.2015.02.002_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/IJNRD.S35632","article-title":"Phosphate control in dialysis","volume":"6","author":"Cupisti","year":"2013","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.krcp.2015.02.002_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00007691-199312000-00025","article-title":"Aluminum toxicity in patients with chronic renal failure","volume":"15","author":"Alfrey","year":"1993","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.krcp.2015.02.002_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2215\/CJN.05060610","article-title":"Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib32","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.krcp.2015.02.002_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.krcp.2015.02.002_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.jrn.2007.10.019","article-title":"Effects of sevelamer and calcium based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial","volume":"18","author":"Suki","year":"2008","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.krcp.2015.02.002_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5414\/CNP65191","article-title":"Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients","volume":"65","author":"Finn","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2369-14-40","article-title":"Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients","volume":"14","author":"Hutchison","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.krcp.2015.02.002_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ndt\/gfu335","article-title":"Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia","volume":"30","author":"Komaba","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2015.02.002_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1525-139X.2011.00849.x","article-title":"The phosphate binder equivalent dose","volume":"24","author":"Daugirdas","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.krcp.2015.02.002_bib39","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.krcp.2015.02.002_bib40","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.krcp.2015.02.002_bib41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/14656566.2013.777041","article-title":"Cinacalcet hydrochloride for the treatment of hyperparathyroidism","volume":"14","author":"Verheyen","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.krcp.2015.02.002_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.otc.2010.01.010","article-title":"Parathyroid surgery in renal failure patients","volume":"43","author":"Dumasius","year":"2010","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.krcp.2015.02.002_bib43","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00268-009-9943-3","article-title":"Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis","volume":"33","author":"Tominaga","year":"2009","journal-title":"World J Surg"}],"container-title":["Kidney Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211913215000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211913215000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T16:52:41Z","timestamp":1651337561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211913215000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2211913215000066"],"URL":"https:\/\/doi.org\/10.1016\/j.krcp.2015.02.002","relation":{},"ISSN":["2211-9132"],"issn-type":[{"value":"2211-9132","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of chronic kidney disease\u2013mineral and bone disorder: Korean working group recommendations","name":"articletitle","label":"Article Title"},{"value":"Kidney Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.krcp.2015.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Korea LLC.","name":"copyright","label":"Copyright"}]}}